Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$965,541
+$703 QoQ
Shares Held
805
-23.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#3,176
of 4,605 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Voya Financial Advisors, Inc. holds $8,834,039 across 10 Drug Manufacturers - General names. LLY ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
31,519 | $1,652,225 | |
| 2 | NVS |
Novartis AG
|
10,020 | $1,570,334 | |
| 3 | AMGN |
Amgen Inc
|
3,137 | $1,135,970 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
805 | $965,541 | |
| 5 | ABBV |
AbbVie Inc.
|
3,390 | $853,059 | |
| 6 | PFE |
Pfizer Inc
|
34,853 | $839,260 | |
| 7 | SNY |
Sanofi
|
14,392 | $613,962 | |
| 8 | JNJ |
Johnson & Johnson
|
1,866 | $473,908 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $965,541 | 805 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $964,838 | 1,049 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,256,301 | 1,169 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,012,501 | 1,327 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $1,114,727 | 1,430 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,157,925 | 1,402 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,227,480 | 1,590 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,247,403 | 1,408 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,608,860 | 1,777 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,342,758 | 1,726 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,123,869 | 1,928 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $957,702 | 1,783 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $841,819 | 1,795 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $570,077 | 1,660 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $588,270 | 1,608 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $455,600 | 1,409 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $430,901 | 1,329 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $353,380 | 1,234 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $1,200,505 | 6,426 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,187,282 | 7,032 | Shares | Defined | 2021-03-05 | |
| 2020-09-30 | $1,081,286 | 7,305 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,667,904 | 10,159 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,809,879 | 13,047 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||